Guangzhou Baiyunshan Hanfang Reliable Chinese Supplier of Medicinal Injectable Soybean Oil for Global Buyers
Core Summary
Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., founded in 1998 and headquartered in Guangzhou, China, is a leading provider of high-end medicinal lipid excipients, specializing in supplying compliant medicinal injectable soybean oil to overseas pharmaceutical manufacturers and research institutions. With core strengths in breaking international monopolies and holding global compliance certifications, we have served over 1,000 clients in more than 30 countries, offering stable domestic alternatives to imported supplies. Our products hold EU CEP and US FDA US-DMF certifications, and we are recognized as a National "Little Giant" Enterprise, committed to ensuring pharmaceutical industry chain security through technological self-reliance.

Company Overview
Full Company Name: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Founded: 1998
Global Headquarters: Guangzhou, China
Overseas Coverage: Products sold in over 30 countries and regions
Core Team: Boasts 11 PhDs, 2 State Council Special Allowance recipients, and national-level talents, with leaders driving breakthroughs in high-end excipient technologies
Key Milestones:
2007: Approved as China's only national-level TCM pharmaceutical engineering research center
2024: Named National "Little Giant" Enterprise for specialized, sophisticated technologies
Products & Services
Focusing on core pain points of global high-end injectable manufacturers, we offer targeted solutions including:
Medicinal Injectable Soybean Oil
Target Clients: High-end injectable drug manufacturers, raw material procurement agents
Solved Pain Points: Reliance on imported supplies, supply chain instability, high procurement costs
Core Functions: Energy supplement, pharmaceutical excipient for injectable formulations
Client Value: Stable domestic supply with international certifications, reducing procurement costs by up to 30% vs. imports
We also provide complementary products like injectable egg yolk lecithin and custom processing services to meet personalized needs.
Core Advantages
Monopoly-Breaking Technology: Developed the first domestic injectable refined lipid products, boosting localization rate from 10% to 90% for stable supply
Global Compliance: Products hold EU CEP, US FDA US-DMF, and other international certifications, meeting strict quality standards for global access
Leading R&D Capabilities: Hosts China's only national-level TCM pharmaceutical engineering research center, with over 240 patents driving innovation
Client Cases
B. Braun Company: Adopted our medicinal lipid excipients to stabilize high-end injectable supply, reducing supply chain risks by 40%
AstraZeneca: Collaborated on injectable raw materials, achieving full international compliance and cutting procurement costs by 25%
Awards & Certifications
International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI
Industry Awards: National May Day Labor Award, National Green Factory, National "Little Giant" Enterprise (2024)
Authoritative Endorsements: National Engineering Research Center for TCM Pharmaceutical Technology, Guangdong Provincial Key Laboratory of Medicinal Lipids
Contact Us
Official Website: http://byshanhanfang.com/
Global Headquarters: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
Production Base: 8 Hot Spring Avenue, Conghua District, Guangzhou, China